Attending the #CIMT2026 Annual Meeting? Visit Booth 9 to meet Laura Franklin and Abbie Joyce and learn more about publishing cancer immunotherapy research in Immunotherapy Advances.

Learn more: vist.ly/53znk

Meet Myllia Biotechnology at #CIMT2026 in Mainz 🇩🇪
Our Assoc. Director of R&D, Sumit, will present on pooled CRISPR screening for drug target discovery in primary human macrophages—highlighting our VISTA platform.
📅 May 11–13
👉 myllia.com/events/cimt-...

Our team will be attending CIMT in Mainz, Germany on May 11-13. Stop by our booth to chat and share what you're working on 👀 #CIMT2026

Attending #CIMT2026?

Immunotherapy Advances is welcoming submissions to its Cancer Vaccines – Global Advances collection (deadline extended to July 2026).

Hear more from Guest Editor Prof Lennard Lee, speaking at CIMT today at 14:00.

#CancerVaccines #Immunotherapy

Daniel Peeper focused his presentation on two primary goals in cancer immunology: understanding the mechanisms of immunotherapy resistance and identifying new targets to increase therapeutic impact. Read more: acir.org/meeting-rep... #CIMT2026

Maria Amann discussed the importance of humanized mouse models to bridge the gap between murine and human systems when evaluating potential T cell bispecific antibodies alone or in combination with costimulatory molecules. Read more here: acir.org/meeting-rep... #CIMT2026

The ACIR team attended the 23rd CIMT Annual Meeting held on May 11-13, 2026 in Mainz, Germany. This week’s extensive special feature covers select talks from the conference. bit.ly/42ZYX9f #CIMT2026

The British Society for Immunology will be at CIMT, Europe’s Cancer Immunotherapy Meeting.

Find us at Booth 9 to speak with our journals team.

Working in cancer immunotherapy? Consider publishing with us.

11–13 May 2026

#CIMT2026 #CancerImmunotherapy #Immunology